Skip to main content

Advertisement

Table 2 The characteristics of the cohort (IQR = interquartile range)

From: Improving the evidence base of Markov models used to estimate the costs of scaling up antiretroviral programmes in resource-limited settings

Total number of patients   5 197
Patient months Overall On ART 136 672 116 306 (85%)
Duration on ART (months) Median IQR 19 (10 to 32)
Age at starting ART (years) Median IQR 37.3 years (32.4 to 42.9)
Sex Female Male 6 379(59.%) 4 356 (41%)
Patient status at end of study period Active Left the scheme Dead 2 922 (56%) 1 834 (34%) 421 (8%)
Baseline CD4+ cell count Median IQR 87 cells/μL (37 to 145)
Baseline viral load (log10) Median IQR 5.22 (4.73 to 5.63)
NNRTI used in first line Nevirapine Efavirenz 2 655 (26%) 6 711 (74%)
NRTI combination in first line Zidovudine + lamivudine Stavudine + lamivudineother other 3 339 (65%) 1 225 (24%) 633 (11%)
Duration of CD4+ cell count monitoring before starting ART (months) Median IQR 1.2 (0.6 to 2.6)
Overall Adherence as measured by monthly pharmacy refill data Median IQR 74.4% (38.4 to 92.3)
  1. IQR=Interquartile Range